Skip to main content
Top

Cardiology and Therapy

2012 - 2024
Volumes
29
Issues
Chevron right icon
Issue 2/2024
Latest issue

About this journal

Cardiology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of cardiovascular therapies and interventions, including devices. The key features of the journal are:

Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.
Open access: All articles published open access (CC-BY-NC)
Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from pre-clinical, clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.
Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.
Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).
Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of £3650/€4500/$5100. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.
Contact: For more information about the journal, including pre-submission enquiries, please contact Matthew Evans at matthew.evans@springer.com

Metadata
Title
Cardiology and Therapy
Coverage
Volume 1/2012 - Volume 13/2024
Publisher
Springer Healthcare
Electronic ISSN
2193-6544
Print ISSN
2193-8261
Journal ID
40119
DOI
https://doi.org/10.1007/40119.2193-6544
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare